doi: 10.1016/j.japh.2023.10.002 [DOI] [PubMed] [Google Scholar] 23.Mahase E
OZEM began trading on May 21, 2024
The mean eGFRs in the GLP-1 RAs users and non-users groups were 73.2 and 75.9 ml/min/1.73 m 2 , respectively
Second, misclassification of the cause of death is a potential concern, however, deaths from unnatural causes of death are commonly subject to autopsy and the validity of suicide is known to be high in Denmark [32]
Specifically, GLP-1a included exenatide (A10BJ01) and liraglutide (A10BJ02), while DPP-4i included sitagliptin (A10BH01), vildagliptin (A10BH02), saxagliptin (A10BH03), alogliptin (A10BH04), and linagliptin (A10BH05)
Returns less than one year are not annualized